Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome.
作者信息
McCombe Jennifer A, Klassen Bryan T, Flanagan Eoin P, Teener James W, Zekeridou Anastasia, Pittock Sean J, McKeon Andrew
机构信息
Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
出版信息
J Neurol. 2023 Sep;270(9):4555-4557. doi: 10.1007/s00415-023-11777-0. Epub 2023 May 18.
Abstract
摘要
相似文献
1
Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome.依库珠单抗治疗甘氨酸受体抗体相关的僵人综合征。
J Neurol. 2023 Sep;270(9):4555-4557. doi: 10.1007/s00415-023-11777-0. Epub 2023 May 18.
2
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.PERM 及相关综合征中的甘氨酸受体抗体：特征、临床特征和结局。
Brain. 2014 Aug;137(Pt 8):2178-92. doi: 10.1093/brain/awu142. Epub 2014 Jun 20.
3
Glycine receptor antibody associated stiff person syndrome with nigrostriatal dopamine loss and levodopa responsiveness.甘氨酸受体抗体相关的僵人综合征伴黑质纹状体多巴胺缺失及左旋多巴反应性。
Parkinsonism Relat Disord. 2023 Jun;111:105404. doi: 10.1016/j.parkreldis.2023.105404. Epub 2023 Apr 25.
4
[A case of stiff-limb syndrome with anti-glycine receptor antibody].[一例伴有抗甘氨酸受体抗体的僵肢综合征病例]
Rinsho Shinkeigaku. 2019 Feb 23;59(2):98-101. doi: 10.5692/clinicalneurol.cn-001239. Epub 2019 Jan 31.
5
Glycine receptor autoantibodies disrupt inhibitory neurotransmission.甘氨酸受体自身抗体破坏抑制性神经递质传递。
Brain. 2019 Nov 1;142(11):3398-3410. doi: 10.1093/brain/awz297.
6
Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders.僵人综合征及其他谷氨酸脱羧酶阳性中枢神经系统疾病中的甘氨酸受体抗体
Neurology. 2013 Nov 26;81(22):1962-4. doi: 10.1212/01.wnl.0000436617.40779.65. Epub 2013 Oct 30.
7
[Stiff-Person Syndrome and Related Autoantibodies].[僵人综合征及相关自身抗体]
Brain Nerve. 2018 Apr;70(4):357-362. doi: 10.11477/mf.1416201008.
8
Successful treatment with rituximab in a patient with stiff-person syndrome complicated by dysthyroid ophthalmopathy.利妥昔单抗成功治疗1例合并甲状腺功能障碍性眼病的僵人综合征患者。
Intern Med. 2010;49(3):237-41. doi: 10.2169/internalmedicine.49.2821. Epub 2010 Feb 1.
9
The One with Many Facets: Anti-Glycine Receptor Antibodies-Related Parkinsonism with Complex Visual Phenomena and Stiff-Limb Syndrome.具有多面性的病例：与抗甘氨酸受体抗体相关的帕金森综合征伴复杂视觉现象和僵肢综合征
Mov Disord Clin Pract. 2024 Aug;11 Suppl 2(Suppl 2):S21-S25. doi: 10.1002/mdc3.14144. Epub 2024 Jun 26.
10
Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.硬人综合征患者的临床和免疫研究。
JAMA Neurol. 2016 Jun 1;73(6):714-20. doi: 10.1001/jamaneurol.2016.0133.
引用本文的文献
1
Pediatric stiff-person syndrome and related disorders: A systematic review.小儿僵人综合征及相关疾病：一项系统综述。
Neurol Sci. 2025 Aug 19. doi: 10.1007/s10072-025-08397-z.
本文引用的文献
1
Anti-complement Agents for Autoimmune Neurological Disease.抗补体药物治疗自身免疫性神经系统疾病。
Neurotherapeutics. 2022 Apr;19(3):711-728. doi: 10.1007/s13311-022-01223-w. Epub 2022 May 12.
2
Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012-2016.2012-2016 年美国侵袭性脑膜炎奈瑟菌的抗菌药物敏感性调查。
J Infect Dis. 2022 Jun 1;225(11):1871-1875. doi: 10.1093/infdis/jiac046.
3
Eculizumab impairs Neisseria meningitidis serogroup B killing in whole blood despite 4CMenB vaccination of PNH patients.尽管对阵发性睡眠性血红蛋白尿症（PNH）患者进行了4CMenB疫苗接种，但依库珠单抗仍会损害全血中对B群脑膜炎奈瑟菌的杀伤作用。
Blood Adv. 2020 Aug 11;4(15):3615-3620. doi: 10.1182/bloodadvances.2020002497.
4
Novel clinical features of glycine receptor antibody syndrome: A series of 17 cases.甘氨酸受体抗体综合征的新临床特征：17 例系列病例。
Neurol Neuroimmunol Neuroinflamm. 2019 Jul 1;6(5):e592. doi: 10.1212/NXI.0000000000000592. eCollection 2019 Sep.
5
Eculizumab in pregnancy: a narrative overview.妊娠期间使用依库珠单抗：叙事性综述。
J Nephrol. 2019 Feb;32(1):17-25. doi: 10.1007/s40620-018-0517-z. Epub 2018 Aug 29.
6
Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders.预测可治疗的僵人综合征谱系障碍的甘氨酸受体调节抗体。
Neurol Neuroimmunol Neuroinflamm. 2018 Jan 23;5(2):e438. doi: 10.1212/NXI.0000000000000438. eCollection 2018 Mar.
7
High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine.尽管接受了脑膜炎球菌疫苗，但接受依库珠单抗（Soliris）治疗的患者仍有患侵袭性脑膜炎球菌病的高风险。
MMWR Morb Mortal Wkly Rep. 2017 Jul 14;66(27):734-737. doi: 10.15585/mmwr.mm6627e1.
8
Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults.依库珠单抗治疗与免疫成人全血对脑膜炎球菌调理吞噬杀伤作用受损
Blood. 2017 Aug 17;130(7):891-899. doi: 10.1182/blood-2017-05-781450. Epub 2017 Jun 19.
9
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab.阵发性夜间血红蛋白尿（PNH）患者长期接受终末补体抑制剂依库珠单抗治疗后对脑膜炎球菌疫苗的血清学反应。
Ann Hematol. 2017 Apr;96(4):589-596. doi: 10.1007/s00277-017-2924-y. Epub 2017 Jan 26.
10
Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis.与依库珠单抗使用相关的感染：预防和 prophylaxis 的建议。
注：这里“prophylaxis”可能拼写有误，正确的可能是“prophylaxis”，意为“预防，预防法” ，整体翻译应该是：与依库珠单抗使用相关的感染：预防建议 。
Curr Opin Infect Dis. 2016 Aug;29(4):319-29. doi: 10.1097/QCO.0000000000000279.
Zotero 插件